These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 9160379)

  • 21. New developments in insulin delivery.
    Khan Ghilzai NM
    Drug Dev Ind Pharm; 2003 Mar; 29(3):253-65. PubMed ID: 12741607
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Alternative delivery routes: inhaled insulin.
    Heinemann L
    Diabetes Nutr Metab; 2002 Dec; 15(6):417-22. PubMed ID: 12678460
    [No Abstract]   [Full Text] [Related]  

  • 23. Insulin pens.
    Gebel E
    Diabetes Forecast; 2011 Jan; 64(1):54-5. PubMed ID: 21337831
    [No Abstract]   [Full Text] [Related]  

  • 24. Oral delivery of insulin for treatment of diabetes: status quo, challenges and opportunities.
    Wong CY; Martinez J; Dass CR
    J Pharm Pharmacol; 2016 Sep; 68(9):1093-108. PubMed ID: 27364922
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacokinetic considerations of new insulin formulations and routes of administration.
    Hoffman A; Ziv E
    Clin Pharmacokinet; 1997 Oct; 33(4):285-301. PubMed ID: 9342504
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Closer to ideal insulin action: ultra fast acting insulins.
    Cengiz E
    Panminerva Med; 2013 Sep; 55(3):269-75. PubMed ID: 24088800
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Recent advancements in oral administration of insulin-loaded liposomal drug delivery systems for diabetes mellitus.
    Wong CY; Al-Salami H; Dass CR
    Int J Pharm; 2018 Oct; 549(1-2):201-217. PubMed ID: 30071309
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Design of oral insulin delivery systems.
    Wong TW
    J Drug Target; 2010 Feb; 18(2):79-92. PubMed ID: 19968567
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Diabetes mellitus and closed-loop insulin delivery.
    Adams G; Clark J; Sahota T; Tanna S; Taylor MJ
    Biotechnol Genet Eng Rev; 2000; 17():455-96. PubMed ID: 11255678
    [No Abstract]   [Full Text] [Related]  

  • 30. Insulin delivery devices--pumps and pens.
    Hirsch IB
    Diabetes Technol Ther; 2010 Jun; 12 Suppl 1():S115-6. PubMed ID: 20515300
    [No Abstract]   [Full Text] [Related]  

  • 31. [Long-term clinical application of wearable artificial endocrine pancreas].
    Konno Y; Nishida K; Shimoda S; Sakakida M; Shichiri M
    Nihon Rinsho; 1997 Nov; 55 Suppl():282-7. PubMed ID: 9434481
    [No Abstract]   [Full Text] [Related]  

  • 32. [Rapid-acting insulin analogs--its biological characteristics and clinical availability].
    Yokono K
    Nihon Rinsho; 2002 Sep; 60 Suppl 9():480-4. PubMed ID: 12387038
    [No Abstract]   [Full Text] [Related]  

  • 33. Though costly, insulin pens facilitate better adherence.
    Reinke T
    Manag Care; 2013 Jun; 22(6):20-1. PubMed ID: 23837286
    [No Abstract]   [Full Text] [Related]  

  • 34. Noninjectable methods of insulin administration.
    Cernea S; Raz I
    Drugs Today (Barc); 2006 Jun; 42(6):405-24. PubMed ID: 16845444
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Technological advancements in diabetes care.
    Christiano AS; Shessler EM
    Adolesc Med State Art Rev; 2010 Apr; 21(1):129-37, x. PubMed ID: 20568560
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Aids for insulin users.
    Berg EG
    Diabetes Forecast; 2014 Jan; 67(1):70-5. PubMed ID: 25868300
    [No Abstract]   [Full Text] [Related]  

  • 37. Hybrid insulin cocrystals for controlled release delivery.
    Brader ML; Sukumar M; Pekar AH; McClellan DS; Chance RE; Flora DB; Cox AL; Irwin L; Myers SR
    Nat Biotechnol; 2002 Aug; 20(8):800-4. PubMed ID: 12134168
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Salicylic acid-based pH-sensitive hydrogels as potential oral insulin delivery systems.
    Demirdirek B; Uhrich KE
    J Drug Target; 2015; 23(7-8):716-24. PubMed ID: 26453167
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [What's new in insulin treatment?].
    Parhofer K
    MMW Fortschr Med; 2004 Mar; 146(12):41-4. PubMed ID: 15357503
    [No Abstract]   [Full Text] [Related]  

  • 40. [Are des-Phe-insulin-containing insulin combinations preferable to regular trade preparations?].
    Sachse G; Federlin K
    Med Klin; 1981 May; 76(11):319-23. PubMed ID: 7017364
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.